Nabil Belfeki

485 citations
49 papers · 220 indexed · h-index 9
Topics
Vasculitis and related conditions (10 papers)Eosinophilic Disorders and Syndromes (6 papers)Renal Diseases and Glomerulopathies (5 papers)

In The Last Decade

Nabil Belfeki

38 papers receiving 218 citations

Peers

Nabil Belfeki
Comparison fields: 5 of 61
  • Infectious Diseases 61
  • Neurology 56
  • Pulmonary and Respiratory Medicine 45
  • Rheumatology 41
  • Epidemiology 32
Replace Aurelia Sega with:
Aurelia Sega Poland
J. Molina Collada Spain
Jasmine Shimin Koh Singapore
Fatma Gül Yurdakul Türkiye
Hanns‐Martin Lorenz Germany
Tatjana Welzel Switzerland
Lucie Pothen Belgium
Fotini Psychou Greece
Jean‐Marie Brisseau France
S. Yu. Chikina Russia
Nabil Belfeki relative to Aurelia Sega Poland Aurelia Sega's profile →
Citations per field
00.5×3.0×
Aurelia Sega · 1×
Citations per year

Countries citing papers authored by Nabil Belfeki

Since Specialization
Citations

This map shows the geographic impact of Nabil Belfeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Belfeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Belfeki more than expected).

Fields of papers citing papers by Nabil Belfeki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Belfeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Belfeki. The network helps show where Nabil Belfeki may publish in the future.

Co-authorship network of co-authors of Nabil Belfeki

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil Belfeki. A scholar is included among the top collaborators of Nabil Belfeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil Belfeki. Nabil Belfeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 1
5 0
6 0
7 3
8 0
9 2
10 0
11 1
12 1
13 4
14 3
15 1
16 13
17 4
18 5
19 9
20 1

About Nabil Belfeki

Nabil Belfeki is a scholar working on Applied Microbiology and Biotechnology, Rheumatology and Nephrology, having authored 49 papers that have together received 220 indexed citations. Recurring topics across this work include Vasculitis and related conditions (10 papers), Eosinophilic Disorders and Syndromes (6 papers) and Renal Diseases and Glomerulopathies (5 papers). The work is most often cited by research in Neurology (56 citations), Infectious Diseases (61 citations) and Hematology (32 citations). Nabil Belfeki has collaborated with scholars based in France, Tunisia and United States. Frequent co-authors include Souheil Zayet, Timothée Klopfenstein, Vincent Gendrin, Alessio Strazzulla, M.H. Houman, I. Ben Ghorbel, S. Diamantis, M. Khanfir, M. Lamloum and A. Bourgarit. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026